American International Group, Inc. Eagle Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$4.26 - $6.51 $187 - $286	-44 Reduced 0.86%	5,099 $26,000
Q4 2023 Feb 13, 2024	SELL	$4.63 - $15.21 $97 - $319	-21 Reduced 0.41%	5,143 $26,000
Q3 2023 Nov 13, 2023	BUY	$15.21 - $22.88 $2,798 - $4,209	184 Added 3.69%	5,164 $81,000
Q2 2023 Aug 04, 2023	SELL	$17.74 - $31.87 $10,945 - $19,663	-617 Reduced 11.02%	4,980 $96,000
Q1 2023 May 12, 2023	BUY	$25.06 - $34.09 $601 - $818	24 Added 0.43%	5,597 $158,000
Q4 2022 Feb 10, 2023	SELL	$24.98 - $39.77 $3,172 - $5,050	-127 Reduced 2.23%	5,573 $162,000
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $581 - $1,036	22 Added 0.39%	5,700 $151,000
Q2 2022 Aug 12, 2022	SELL	$41.26 - $51.35 $35,813 - $44,571	-868 Reduced 13.26%	5,678 $252,000
Q1 2022 May 13, 2022	SELL	$44.58 - $52.6 $17,965 - $21,197	-403 Reduced 5.8%	6,546 $324,000
Q4 2021 Feb 11, 2022	SELL	$45.82 - $56.9 $15,349 - $19,061	-335 Reduced 4.6%	6,949 $354,000
Q3 2021 Nov 12, 2021	SELL	$43.79 - $55.78 $11,560 - $14,725	-264 Reduced 3.5%	7,284 $406,000
Q2 2021 Aug 13, 2021	BUY	$36.86 - $44.5 $19,646 - $23,718	533 Added 7.6%	7,548 $323,000
Q1 2021 May 07, 2021	SELL	$40.32 - $50.97 $3,588 - $4,536	-89 Reduced 1.25%	7,015 $293,000
Q4 2020 Feb 12, 2021	SELL	$41.72 - $51.34 $22,320 - $27,466	-535 Reduced 7.0%	7,104 $331,000
Q3 2020 Nov 04, 2020	BUY	$37.02 - $51.28 $74 - $102	2 Added 0.03%	7,639 $325,000
Q2 2020 Aug 12, 2020	BUY	$43.24 - $55.02 $55,217 - $70,260	1,277 Added 20.08%	7,637 $366,000
Q1 2020 May 04, 2020	SELL	$34.37 - $60.07 $10,723 - $18,741	-312 Reduced 4.68%	6,360 $293,000
Q4 2019 Feb 05, 2020	SELL	$54.32 - $64.31 $10,320 - $12,218	-190 Reduced 2.77%	6,672 $401,000
Q3 2019 Nov 08, 2019	SELL	$53.25 - $59.98 $11,289 - $12,715	-212 Reduced 3.0%	6,862 $388,000
Q2 2019 Aug 13, 2019	SELL	$46.61 - $58.45 $40,923 - $51,319	-878 Reduced 11.04%	7,074 $394,000
Q1 2019 May 06, 2019	SELL	$38.66 - $51.82 $11,520 - $15,442	-298 Reduced 3.61%	7,952 $401,000
Q4 2018 Feb 13, 2019	SELL	$36.72 - $67.73 $4,259 - $7,856	-116 Reduced 1.39%	8,250 $332,000
Q3 2018 Nov 09, 2018	BUY	$66.65 - $83.86 $39,590 - $49,812	594 Added 7.64%	8,366 $580,000
Q2 2018 Aug 08, 2018	BUY	$51.25 - $76.62 $134,941 - $201,740	2,633 Added 51.24%	7,772 $588,000
Q1 2018 May 07, 2018	SELL	$52.16 - $66.86 $67,390 - $86,383	-1,292 Reduced 20.09%	5,139 $271,000
Q4 2017 Feb 09, 2018	SELL	$49.6 - $60.87 $6,497 - $7,973	-131 Reduced 2.0%	6,431 $344,000
Q3 2017 Nov 09, 2017	BUY	$46.62 - $60.36 $305,920 - $396,082	6,562	6,562 $391,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account